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Background/aim: Peroneal neuropathy at the fibular head (PNFH) is one of the most common entrapment neuropathies. Our aim in
this study was to analyze the efficiency of ultrasonography in the diagnosis of PNFH.
Materials and methods: The study included 15 peroneal nerves of 12 patients with PNFH and 24 peroneal nerves of 12 healthy controls.
PNFH confirmation was based on clinical and electrophysiological findings. All patients and controls underwent ultrasonographic
evaluations for peroneal nerves. The cross-sectional area (CSA) was measured. Echogenicity of the nerve was evaluated by comparing it
with the adjacent connective tissue deep under the subcutaneous fat.
Results: CSA measurement of the peroneal nerve is a valuable diagnostic tool in predicting PNFH (AUC: 0.87, 95% CI: 0.73–1.00, P
< 0.01). The CSA cutoff value for diagnosing PNFH was found to be 0.115 cm2 with 80% sensitivity and 99% specificity. Hypoechoic
peroneal nerve in patients with PNFH was very frequent.
Conclusion: Ultrasonography is a useful technique in diagnosing PNFH. In addition to clinic and electrophysiological findings, it may
improve diagnostic performance.
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1. Introduction
Peroneal neuropathy is one of the most common
mononeuropathies in the lower extremities and usually
occurs at the fibular head where the nerve is superficial
and vulnerable to injury. Peroneal neuropathy at the fibular
head (PNFH) can result from a variety of conditions such
as trauma, traction injuries, masses, entrapment, and
external compression from prolonged immobilization.
Patients with PNFH usually have weak toe and ankle
dorsiflexion, weak foot eversion, and numbness over the
lower lateral calf and the dorsum of the foot. Therefore,
patients with sciatic neuropathy, lumbosacral plexopathy,
or L5 radiculopathy may present a similar clinical pattern
and differentiating PNFH from these conditions may
sometimes be difficult (1,2).
The diagnosis of PNFH is based on clinical findings
and electrophysiological studies. Electrophysiological
evaluation is usually adequate for the diagnosis of PNFH.
However, additional tests may be required, especially in
nonlocalizing peroneal nerve lesions with severe axonal
loss. Although ultrasonography has proven to be useful
in entrapment neuropathies of the upper extremities

(3,4), there are few studies that investigated the validity of
ultrasonography in the diagnosis of PNFH (5–8).
In this study, we analyzed ultrasonographic findings
in patients with PNFH and evaluated the efficiency of
ultrasonography in the diagnosis of PNFH.
2. Materials and methods
2.1. Patients and controls
This study included 15 peroneal nerves of 12 patients with
PNFH and 24 peroneal nerves of 12 healthy controls. Three
patients had PNFH bilaterally. The inclusion criteria were
based on both clinical and electrophysiological findings.
To make the clinical diagnosis, we looked for weak toe
and ankle dorsiflexion, weak foot eversion, and sensory
loss over the lateral calf and the dorsum of the foot. Local
pain or Tinel’s sign may also be present at the fibular head.
Patients with any symptoms of polyneuropathy were
excluded from the study. Patients with diseases related
to polyneuropathy, hypothyroidism, diabetes mellitus,
amyloidosis rheumatoid arthritis, or pregnancy were
also excluded from the study. Histories of acute trauma,
peroneal surgery, and duration of symptoms longer than
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12 weeks were other exclusion criteria. One patient who
had peroneal nerve mass bilaterally was excluded from
the study after the ultrasonographic evaluation. Healthy
volunteers included subjects with no symptoms or signs
of PNFH or systemic diseases that could be related to
polyneuropathy.
The institutional ethics committee approved the study
and all participants gave informed consent. The study
was conducted according to the Declaration of Helsinki’s
Ethical Principles for Medical Research Involving Human
Subjects.
2.2. Electrophysiological studies
Electrophysiological
studies
included
needle
electromyography (EMG) and nerve conduction studies
(NCS) and were performed on a Medelec Synergy machine
(Oxford Instruments Medical, Inc., Oxford, UK). Motor
and sensory NCS were performed using the standard
techniques of supramaximal percutaneous stimulation.
Skin temperature of the extremities was between 31 and
32 °C.
Peroneal and tibial motor NCS, including F-waves,
were performed bilaterally. Peroneal nerve compound
muscle action potential (CMAP) was recorded from the
extensor digitorum brevis (EDB) muscle by stimulating
over the ankle, below the fibular head and popliteal fossa
(the distance across the fibular head was 10–12 cm). If
the recording of the EDB muscle could not localize the
lesion, the peroneal motor study was repeated, recording
from the tibialis anterior muscle by stimulating the area
below the fibular head and popliteal fossa. The tibial nerve
CMAP was recorded from the abductor hallucis muscle by
stimulating the area posterior to the medial malleolus and
at the popliteal fossa.
For sensory NCS we evaluated superficial peroneal
and sural nerves bilaterally and antidromically. The
stimulation was done at the lateral calf and recorded from
the lateral ankle for the superficial peroneal nerve. For the
sural nerve the stimulation was done at the posterior of the
lateral calf and recorded from the posterior to the lateral
malleolus. We compared the findings with the reference
values used in our laboratory. Needle EMG studies of the
tibialis anterior, extensor hallucis longus, peroneus longus,
gastrocnemius, short head of biceps femoris, and gluteus
medius muscles were also performed.
The electrodiagnostic criteria for PNFH were: 1)
absolute slowing (<44 m/s) of the motor conduction
velocity across the fibular head or 2) conduction block
across the fibular head (any drop in amplitude or area
of >20%). The reduced sensory nerve action potential
amplitude of the superficial peroneal nerve, the reduced
compound muscle action potential amplitude of the EDB
muscle, or needle EMG abnormalities of peroneal nerve
innervated muscles were additional criteria.
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2.3. Ultrasonographic studies
All patients and controls underwent ultrasonographic
evaluation of the peroneal nerve. An Aplio 500A (Toshiba
Med. Systems Co., Ottowara, Japan) and a 7–14 MHz linear
array transducer were used. Ultrasonographic images
were taken when patients were in the lateral decubitus
position with their knees semiflexed (20° to 30°). At least
5 cm of bilateral peroneal nerves just proximal to the
level of fibular head was evaluated by ultrasonography.
On transverse images, the common peroneal nerve was
located between the fibular head laterally and the peroneus
longus tendon medially. The course of the peroneal
nerve was also evaluated in the sagittal plane (Figures
1 and 2). The cross-sectional area (CSA) of the nerve in
transverse views was measured using continuous manual
tracing, excluding the hyperechoic epineurial rim (Figure
3). The largest measurement obtained after multiple
measurements was accepted as the actual CSA. Three or
more CSA measurements for each nerve were done.

Figure 1. Normal peroneal nerve in sagittal ultrasonographic
view (arrow heads) shows isoechoic nerve compared with
adjacent connective tissue deep under the subcutaneous fat.

Figure 2. Extended-field-of-view longitudinal ultrasonographic
image shows thick, hypoechoic peroneal nerve around the
fibular head (arrow heads).
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Figure 3. Cross-sectional area measurement of the nerve in
transverse view using continuous manual tracing method,
excluding the hyperechoic epineurial rim.

Echogenicity of the nerve was also evaluated. The
adjacent connective tissue deep under the subcutaneous
fat was used for comparison. The nerve was classified as
hypoechoic if nerve reflectivity was low (Figure 2) and
isoechoic when the nerve had the same reflectivity as the
adjacent connective tissue (Figure 1). Nerves in control
subjects had similar echo and architecture to tendons on
ultrasonography (Figure 1).
A radiologist with more than 10 years of experience in
nerve and soft tissue ultrasonography did the evaluations.
The radiologist was blinded to the subject groups. The
interval between ultrasonographic evaluation and the
electrophysiological study was 1 week or less.
2.4. Statistical analysis
Statistical analyses were performed using SPSS 21.0 (IBM
Corp., Armonk, NY, USA). Variables were investigated
using Shapiro–Wilk tests to determine whether they
were normally distributed. For the variables that were not
normally distributed, a log 10 transformation was used to
provide a normal distribution. Descriptive analyses are
presented using mean ± standard deviation and number
(%). Student’s t and chi-square tests were used to evaluate
variables and results with P < 0.05 were considered
significant. A receiver operating characteristics (ROC)
curve analysis was performed to assess the efficiency of the
comparative techniques in PNFH diagnosis to determine
sensitivity, specificity, and cutoff points.
3. Results
The mean age of the patients was 47.3 ± 14.9 years and the
controls had a mean age of 47.3 ± 13.4 years. Duration of
symptoms was 5.62 ± 4.35 weeks. Both groups had 9 men
(75%) and 3 women (25%). No significant differences in
age or sex were noted between patients and controls. The
demographic, clinical, and ultrasonographic characteristics
of patients and controls and electrophysiological findings

of the patients are summarized in Table 1. Three patients
had PNFH bilaterally and nine patients had PNFH
unilaterally. There were significant differences in CSA
measurements between patients and controls (Table 2).
CSAs of peroneal nerves and echogenicity showed no
significant differences between the control group and the
normal side of the patient group (Table 2). In the patient
group, there were significantly more hypoechoic peroneal
nerves than in the control group (Table 2).
ROC curve analysis determined that CSA measurement
was a valuable diagnostic tool in predicting PNFH (AUC:
0.87, 95% CI: 0.73–1.00, P < 0.01). The CSA cutoff value
for diagnosing PNFH was 0.115 cm2 with 80% sensitivity
and 99% specificity (Figure 4).
4. Discussion
Entrapment neuropathy of the peroneal nerve is caused
mostly by its compression at the level of the fibular head
(6). Reported risk factors are marked weight loss, forcible
strength injury, trauma, surgery at nerve localization,
and compression from prolonged immobilization (1,5).
Other possible causes are compression by intrinsic and
extrinsic nerve tumors, synovial cyst, ganglia, bone, and
soft tissue tumors. Electrophysiological evaluation can
usually localize the level of the nerve lesion but cannot give
information about the underlying pathology. In our study,
we incidentally found that one of our patients had a nerve
sheet tumor bilaterally and that individual was excluded
from the study. Ultrasonography is a useful and widely
available technique for evaluating and differentiating these
pathologies from idiopathic compression (9).
The efficiency of ultrasonography is proved in
compressive neuropathies (3,4,9). There are very few
studies that have investigated ultrasonographic findings in
PNFH (5–8). Visser et al. (5) described a cutoff value of
0.08 cm2 with a sensitivity of 90% after assessment of CSA
in the most thickened part of the common fibular nerve.
The study was designed to localize the level of pathology
with ultrasonography. In nearly one-third of their patient
group no localizations were done by electrophysiological
testing. They also had a patient-control group with foot
drop in whom diagnoses other than common fibular
neuropathy were made. We believe these are the reasons
for their relatively lower cutoff values.
Lo et al. (6) enrolled five patients with peroneal
neuropathy and they measured the maximum transverse
length, maximum transverse breadth, ratio of these two
parameters, and CSA. They indicated that sonography
was useful in diagnosing PNFH and hypothesized that
the negative correlation between motor amplitude and
transverse length and area suggested a relationship
between nerve swelling and axon loss (6). In this study,
controls had a mean CSA of 0.10 cm2 (0.06–0.14 cm2).
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Table 1. Ultrasonographic findings and motor and sensory nerve conduction studies of the patients.

Age/Sex

Side

Ultrasonography

Nerve conduction studies

CSA (cm2)

Echo

Right

R

L

R

L

SA (µV)

MA (mV)

MCV (m/s)

SA (µV)

MA (mV)

MCV (m/s)

Left

52/M

L

0.08

0.33

I

H

9.4

2.0/2.0/2.0

49.6/52.5

NR

NR

-

38/F

R, L

0.14

0.14

H

H

12

2.6/2.1/1.9

42.5/35.1

9

1.1/1.1/0.9

44.7/37.3

43/F

L

0.08

0.23

I

H

18.5

8.8/8.5/8.5

52.4/68.6

11.8

5.0/5.0/1.2

29.1/24.4

72/M

L

0.11

0.75

I

H

8

4.4/3.5/3.5

43.1/44.2

NR

NR

-

67/M

L

0.07

0.25

I

H

7.2

2.0/2.0/2.0

45/44

NR

NR

-

46/M

L

0.11

0.12

I

I

7.2

6.8/5.7/5.3

45.3/44

7.9

NR

-

61/M

R, L

0.07

0.08

I

H

10.6

2.1/2.1/2.0

44/39

NR

2.6/2.5/2.3

41/38

41/M

R

0.26

0.07

H

I

NR

3.8/2.2/1.8

41.8/39

12.2

5.9/4.9/4.8

44.8/44.7

47/M

L

0.07

0.10

I

I

5.1

2.0/2.0/2.0

44/44

11.1

0.7/0.7/0.7

44/39

32/M

R

0.35

0.14

H

H

13.1

3.3/2.5/2.3

46.6/39

18.7

2.2/2.0/2.0

43/44

18/M

R

0.53

-

H

-

19.8

7.2/6.6/0.6

49.6/38.5

20.3

5.7/5.5/5.5

50/47.4

50/F

R, L

0.22

0.30

H

H

9.2

NR

-

9.5

NR

-

F: Female, M: male, CSA: cross-sectional area, R: right, L: left, H: hypoechoic, I: isoechoic, Echo: echogenicity. SA: sensory amplitude,
MA: motor amplitude, MCV: motor conduction velocity, NR: no response.
Ultrasonographic measurements in electrophysiologically pathologic nerves are in bold.
Pathologic electrophysiological values are in bold.
Table 2. Comparison of peroneal nerve CSA and echogenicity of the affected and the unaffected sides of patients with controls.
Patients

CSA
US

Healthy
controls

USP

Mean
± SD
Range

0.258
± 0.184
(0.07–0.75)

0.0913
± 0.018
(0.06–0.12)

0.0913
± 0.026
(0.07–0.14)

H (n)

12 (80%)

2 (8.3%)

1 (12.5%)

I (n)

3 (20%)

22 (91.7%)

7 (87.5%)

Patients vs. controls

USP vs. controls

P-value

P-value

<0.001

t: 4.45

0.087

<0.001

χ2: 20.6

0.726

χ2: 0.12

USP: Unaffected side of patients, CSA: cross-sectional area, US: ultrasonography, H: hypoechoic, I: isoechoic.

No cutoff was calculated, but patients with compressive
neuropathy had CSAs of 0.21 cm2 and above. In this study,
the number of patients with common fibular neuropathy
was low. They also had patients with extremely enlarged
nerves (0.21–0.31 cm2), as we had in our patient group
(0.07–0.75 cm2).
In the study of Meylaerts et al., the authors evaluated
six patients with PNFH after weight loss (7). They
measured CSA, including both long and short transverse
diameters, and also evaluated differences in echogenicity.
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They found a mean CSA of 0.18 ± 0.5 cm2 in the control
group. They indicated that CSA in the affected peroneal
nerve did not differ much from that of the unaffected side;
the most important sonography finding in the pathological
peroneal nerve was the presence of spots with low signal
reflectivity (7). We think that the reason for higher CSAs
in controls and possibly in patients could be the technique
used in calculating CSA. The ultrasonographic technique
was not described in detail, but as far as we can ascertain
from the figures, CSA measurements were done using an
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Figure 4. ROC curve analysis for CSA measurement for PNFH
diagnosis.

automated ellipsoid ROI and the area measured did not
exclude the echogenic rim around the nerve. This would
explain the higher CSA measurements. In our study,
we use manual tracing and excluded the echogenic rim
around the nerve. We found a mean CSA of 0.0913 ± 0.018
cm2 in the control group and 0.0913 ± 0.026 cm2 in the
unaffected side of the patient group. The difference was not
statistically significant. The mean CSAs that we measured
were closer to the other reported data (5,6,9). In these
studies, there was lower echo in the affected sides. We used
a similar evaluation method and found lower echogenicity
in the affected peroneal nerve, which agrees with all other
compressive neuropathies. In our study, there were two
(8.3%) hypoechoic peroneal nerves in the control group
and one (12.5%) in the unaffected side of the patient group.

Although a cutoff value of 0.115 cm2 was calculated in our
study, three peroneal nerves had CSA value below this
limit (0.07, 0.08, and 0.10 cm2). In two of these patients,
nerve echogenicity did not solve the diagnosis problem
because nerve echogenicity was normal; in one patient,
the nerve was as hypoechoic as pathological nerves with
high CSA.
Recently, Kim et al. described a cutoff value of 0.117
cm2 with sensitivity of 85% and specificity of 90%, which
is very close to our findings (8). The reason for relatively
high specificity in our study could be the lower number of
patients and extreme enlargement seen in a large percentage
of them. Kim et al. noted that comparing the difference
between the symptomatic side with the asymptomatic side
or calculating the ratio would be helpful in diagnosis of
PNFH (sensitivity 83% and 72%, specificity 97% and 97%)
(8). When comparing the asymptomatic side with controls,
we noted no significant difference in CSA measurements
and found it unnecessary to compare differences between
symptomatic sides and asymptomatic sides. However, we
still believe it would be helpful in clinical settings. In our
patient group, four patients had bilateral PNFH, and in one
an ultrasonographic demonstration could not be done for
the asymptomatic side. In eight patients there was PNFH
unilaterally. In only one of eight patients with unilateral
PNFH was the difference and the ratio of the symptomatic
and asymptomatic side not concordant with the findings
that Kim et al. described (8).
The relatively lower number of patients and subjective
evaluation of echogenicity were limitations of our study.
We noted isoechoic or normal nerve echogenicity in
three (20%) affected nerves. Objective evaluation of nerve
echogenicity could be a solution to this problem. We
believe that the cause of hypoechoic nerves in controls
could be PNFH with hidden clinical findings. Not doing
electrophysiological evaluation of controls is another
limitation of our study.
We think that CSA measurement of the peroneal
nerve at the level of the fibular head and evaluation
of nerve echogenicity by ultrasonography are useful
techniques in diagnosing PNFH. In addition to clinical
and electrophysiological findings, ultrasonography may
improve diagnostic performance.
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